PPLI Short Interest Climbs to a Year High Before November Print

People Incorporated reports Q3 results on November 3, and the stock is arriving at that date under pressure: down 5.2% on the week to $37.29, carrying the highest short position in at least a year, and drawing an unusually defensive options posture that has flipped sharply in the past two sessions.

Short interest has climbed to 15.9% of the free float, up roughly 5% on the week and 20% over the past month. That is a meaningful build from the mid-September level, when SI was running closer to 12.5% of float. The official FINRA fortnightly count, settled October 15, put short shares at 11.6 million with a days-to-cover of 11, confirming the trend is not a data artefact. Despite the size of the short position, the borrow market remains relatively uncrowded: availability is running at 422%, meaning there are more than four shares available to lend for every one already borrowed, well above the 52-week trough of 252%. Cost to borrow has been drifting higher, up 22% on the week to 0.58%, but that is still low in absolute terms. The lending market, then, is not placing constraints on further short-building; anyone wanting exposure to the downside can get it cheaply.

Options positioning shifted dramatically in the past two sessions. The put/call ratio, which spent most of September and early October below 0.1, spiked to 3.74 on Monday and pulled back to 2.90 on Tuesday, still 2.5 standard deviations above its 20-day mean of 0.54. That is a sharp rotation toward protective puts, coinciding almost exactly with the acceleration in the short interest build over the same period. The 52-week high on the PCR is 10.41, so the current level is not an extreme outlier, but the speed of the move from near-zero is notable. The ORTEX short score is 68.6, placing the stock in the 7th percentile on the short score rank factor, meaning very few stocks in the universe carry a more bearish short-positioning signal.

The Street is constructive but has been trimming its ambitions. Analysts broadly retained Buy-equivalent ratings through August, and several raised price targets following the Q2 print, including Benchmark at $70, Truist Securities at $62, and Citigroup at $52. JP Morgan assumed coverage in September with an Overweight and a $54 target. StoneX, however, cut its target from $70 to $63 while keeping its Buy rating, on September 24. The mean target across the group is $56.80, implying roughly 52% upside to the current $37.29 price. That gap is the central tension: the Street sees significant value, and EPS surprise ranks in the 99th percentile, meaning the company has a strong track record of beating estimates. But the EV/EBITDA of 11x has compressed about 0.4 turns over the past 30 days, and the EV/EBIT factor ranks in just the 2nd percentile, suggesting the market is skeptical about the quality of the earnings base. The bull case centres on the People segment's operational momentum following the Care.com divestiture and the discontinuation of Search, while the bear case rests on execution risk in a company still being restructured and ongoing uncertainty tied to Google's litigation and MGM-related assets.

The activist register adds another layer of complexity. Three holders are on the SEC 13D register, meaning they have disclosed an active intent rather than a purely passive stake. Barry Diller filed a Schedule 13D/A in June 2026, raising his position to 8.9% from 8.1%. Jennifer Stier filed as recently as September 29, lifting her stake to 7.9% from 7.3% across four filings since February 2025. Joseph Levin, who filed once in January 2025, is disclosed at 1.3%. Helikon Investments filed a 13G/A on October 6, the most recent disclosure on the register, showing its stake had grown to 11.44% from 7.6%, making it the largest institutional holder by percentage. The standard disclosure caveat applies: these stakes are as-last-disclosed around the 5% threshold and positions can change without a new filing once a holder falls below that level.

The stock has reacted positively to recent earnings in the first session, gaining around 4.9% the day after the August 2026 print, though that gain eroded to a 5% loss over the following five days. The November 3 release will test whether a stock carrying 15.9% short interest, a put/call ratio running 2.5 standard deviations above its recent norm, and a 52% gap to mean analyst targets can repeat that pattern, or whether the short position reflects something the Street's targets have yet to price in.